Literature DB >> 7448724

The lack of relationship between estrogen receptor status and response to chemotherapy.

R Hilf, M L Feldstein, E D Savlov, S L Gibson, B Seneca.   

Abstract

The possible relationship between estrogen receptors and response of breast cancer patients to chemotherapy was examined in two situations: patients with advanced disease and patients receiving post-surgical adjuvant treatment. In 73 patients with disseminated disease, no relationship between ER status and response to cytotoxic chemotherapy was observed. At this time, 44 of these cases have undergone extramural review; in these 44 cases, we observed no significant relationship between ER status and response to chemotherapy. In a series of 52 patients receiving adjuvant therapy, 27 patients were classified as failures due to recurrence. ER status did not offer prognostic value for failure of patients treated with postsurgical adjuvant therapy. We conclude that the prognostic value of ER data in nonhormonal therapy settings remains to be proven

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7448724     DOI: 10.1002/1097-0142(19801215)46:12+<2797::aid-cncr2820461411>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Relationship of estrogen and progesterone receptors to prognosis in breast cancer.

Authors:  G A Gelbfish; A L Davidson; S Kopel; B Schreibman; J S Gelbfish; G A Degenshein; B L Herz; J N Cunningham
Journal:  Ann Surg       Date:  1988-01       Impact factor: 12.969

2.  A prospective analysis of immunohistochemically determined hormone receptors and nuclear features as predictors of early recurrence in primary breast cancer.

Authors:  M Stierer; H Rosen; R Weber; H Hanak; L Auerbach; J Spona; H Tüchler
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

3.  Estrogen receptor status of advanced breast cancer immediately before chemotherapy does not predict for response.

Authors:  J F Stewart; J L Hayward; R D Rubens; R J King
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

4.  The potential biomarkers in predicting pathologic response of breast cancer to three different chemotherapy regimens: a case control study.

Authors:  Linbo Wang; Zhinong Jiang; Meihua Sui; Jianguo Shen; Chaoyang Xu; Weimin Fan
Journal:  BMC Cancer       Date:  2009-07-11       Impact factor: 4.430

5.  Relation of estrogen and/or progesterone receptor content of breast cancer to patient outcome following adjuvant chemotherapy.

Authors:  B Fisher; C K Redmond; D L Wickerham; H E Rockette; A Brown; J Allegra; D Bowman; D Plotkin; J Wolter
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

Review 6.  Chemotherapy of breast cancer.

Authors:  L S Perlow; J F Holland
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

7.  Oestrogen and progesterone cytosolic receptors in clinically inflammatory tumours of the human breast.

Authors:  J C Delarue; F May-Levin; H Mouriesse; G Contesso; H Sancho-Garnier
Journal:  Br J Cancer       Date:  1981-12       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.